Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MM

Mark Munson — 27 Patents

ABArray Biopharma: 19 patents #28 of 335Top 9%
SASanofi: 7 patents #185 of 1,881Top 10%
Bristol-Myers Squibb: 7 patents #761 of 3,969Top 20%
Genentech: 1 patents #1,597 of 2,392Top 70%
GEGenzyme: 1 patents #498 of 891Top 60%
Acton, MA: #82 of 1,334 inventorsTop 7%
Massachusetts: #3,752 of 88,656 inventorsTop 5%
Overall (All Time): #142,059 of 4,157,543Top 4%
27 Patents All Time
Mark Munson has been granted 27 US patents while listed as an inventor at Array Biopharma. The first was granted in 2006 and the most recent in August 2021. Mark Munson ranks #142,059 of 4,157,543 US inventors in our database (top 3.4%). Patent records list Mark Munson in Acton, MA, US.

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11098056 UDP glycosyltransferase inhibitors and methods of use Sungtaek Lim, Robert H. Barker, Jr., Mary A. CROMWELL, Elina Makino, Bradford H. Hirth +7 more 2021-08-24
10774052 Heteroaryl compounds and uses thereof Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +6 more 2020-09-15 $11,801,000
10669269 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2020-06-02
10618902 Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +9 more 2020-04-14 $12,078,000
10189794 Heteroaryl compounds and uses thereof Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +6 more 2019-01-29 $8,046,000
10065966 Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +9 more 2018-09-04 $6,121,000
9809590 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2017-11-07 $14,586,000
9695132 Heteroaryl compounds and uses thereof Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +6 more 2017-07-04
9663524 Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +9 more 2017-05-30 $31,272,000
9321786 Heteroaryl compounds and uses thereof Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Deqiang Niu, Joseph McDonald, Zhendong Zhu +6 more 2016-04-26 $8,777,000
9174981 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Mark Laurence Boys, Robert Kirk DeLisle, Erik James Hicken, April L. Kennedy, David A. Mareska +7 more 2015-11-03 $10,851,000
8987251 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Hicks +13 more 2015-03-24 $16,577,000
8895550 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Hicks, Erik James Hicken, Joseph P. Lyssikatos +3 more 2014-11-25 $3,103,000
8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Mark Laurence Boys, Michael Bradley, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy +7 more 2014-09-23 $3,108,000
8680114 AKT protein kinase inhibitors Ian S. Mitchell, Keith L. Spencer, Peter J. Stengel, Yongxin Han, Nicholas C. Kallan +10 more 2014-03-25 $7,132,000
8575145 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Laura L. Celeste, T. Gregg Davis, Robert Kirk DeLisle, Julie Marie Greschuk +13 more 2013-11-05 $8,282,000
8557809 Triazolopyridine compounds as PIM kinase inhibitors Shelley Allen, Robert Kirk DeLisle, Julie Marie Greschuk, Erik James Hicken, Joseph P. Lyssikatos +3 more 2013-10-15 $8,256,000
8518983 P38 inhibitors and methods of use thereof David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2013-08-27 $8,446,000
8202899 Pyrazole urea derivatives used as kinase inhibitors Brian Baer 2012-06-19 $4,213,000
8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Shelley Allen, Julie Marie Greschuk, Nicholas C. Kallan, Fredrik P. Marmsater, James P. Rizzi +5 more 2012-03-20 $3,648,000
8044083 Kinase inhibitors and methods of use thereof Robert D. Groneberg, Laurence E. Burgess, Darren Harvey, Ellen Laird, James P. Rizzi +3 more 2011-10-25 $1,398,000
8039639 Kinase inhibitors and methods of use thereof Robert D. Groneberg, Laurence E. Burges, Darren Harvey, Ellen Laird, James P. Rizzi +3 more 2011-10-18 $647,000
8026233 P38 inhibitors and methods of use thereof Kevin W. Hunt, Christopher T. Clark, Ganghyeok Kim, Laurence E. Burgess, James P. Rizzi 2011-09-27 $1,129,000
8017641 P38 inhibitors and methods of use thereof David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2011-09-13 $1,002,000
7799782 P38 inhibitors and methods of use thereof David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi, Martha E. Rodriguez +5 more 2010-09-21 $2,697,000